Syschem India Ltd Stock Price Today (NSE: SYSCHEM)
Fundamental Score
Syschem India Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Syschem India Ltd share price today is ₹43.06, down 4.46% on NSE/BSE as of 30 March 2026. Syschem India Ltd (SYSCHEM) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹237.63 (Cr). The 52-week high for SYSCHEM share price is ₹62.00 and the 52-week low is ₹35.33. At a P/E ratio of 52.46x, SYSCHEM is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 0.62% and a debt-to-equity ratio of 0.00.
Syschem India Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Syschem India Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Syschem Share Price: A ROCE-Focused Financial Analysis
The Indian pharmaceutical sector is currently experiencing a period of nuanced growth, driven by both domestic demand and increasing export opportunities, particularly in generic drugs. This analysis focuses on Syschem share price, currently trading at ₹52.209999, and its financial health as indicated by its Return on Capital Employed (ROCE) and Price-to-Earnings (PE) ratio. A deep dive into ROCE reveals critical operational efficiencies.
Syschem India Ltd. exhibits a PE ratio of 52.46, which suggests that investors have high expectations for future earnings growth. However, its ROCE stands at a mere 1.47%. This low ROCE, when benchmarked against its PE, indicates that the company is not efficiently utilizing its capital to generate returns relative to its market valuation. This contrasts sharply with the management quality and operational effectiveness of some of its peers. For example,
Mankind Pharma Ltd generally enjoys much higher ROCE metrics, reflecting stronger capital allocation and operational execution.The comparatively low ROCE of 1.47% also significantly impacts Syschem's economic moat, or its competitive advantage. A robust ROCE typically indicates a company's ability to generate above-average returns, deterring competitors and ensuring long-term profitability. Syschem's current ROCE suggests that its ability to sustain a competitive advantage in the pharmaceutical market is potentially weak, requiring careful scrutiny of its operational strategies and cost management.
Further examination of Syschem's financial statements, including detailed analysis of its cost structure, asset turnover, and debt levels, is crucial to understand the drivers behind its ROCE. A sustained improvement in ROCE is necessary to justify its current PE ratio and demonstrate a capacity for long-term value creation. This observational analysis forms part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra, providing a detailed perspective on the financial performance of Syschem India Ltd.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Syschem India Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SYSCHEM across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Robust Profit Growth (396.88%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (118.01%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (33.94% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (16.40% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (17.64% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (64.56x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (56.71%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (0.62%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (1.47%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (1.98%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 52.46x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Negative Free Cash Flow (₹-78.30 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 0.18%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Syschem India Ltd Financial Statements
Comprehensive financial data for Syschem India Ltd including income statement, balance sheet and cash flow
About SYSCHEM (Syschem India Ltd)
Syschem India Ltd is a dynamic pharmaceutical company committed to advancing healthcare through the development and production of high-quality active pharmaceutical ingredients (AP...Is) and specialized chemical products. With a strong focus on research and innovation, Syschem serves as a trusted partner to pharmaceutical formulators worldwide, providing essential building blocks for a diverse range of medications. The company's state-of-the-art manufacturing facilities adhere to stringent regulatory standards, ensuring the purity, safety, and efficacy of all its offerings. Syschem prides itself on its commitment to sustainable practices, striving to minimize its environmental footprint while delivering exceptional value to its customers. Syschem's diverse product portfolio encompasses a wide spectrum of APIs and intermediates, catering to various therapeutic areas. Core products include a range of beta-lactam antibiotics, crucial in combating bacterial infections. Furthermore, the company specializes in the production of specialty solvents, vital for various pharmaceutical processes, including purification and extraction. Syschem's dedicated research and development team continuously explores new synthetic routes and process improvements to enhance product quality and efficiency. This commitment to innovation allows Syschem to stay at the forefront of the pharmaceutical industry, addressing evolving market needs and delivering cutting-edge solutions. Beyond its core product offerings, Syschem extends its capabilities through contract manufacturing services, providing customized solutions to meet the specific requirements of its clients. This allows pharmaceutical companies to leverage Syschem's expertise and infrastructure to accelerate product development and manufacturing, while maintaining the highest quality standards. Syschem's customer-centric approach, coupled with its unwavering commitment to excellence, has solidified its position as a reliable and trusted partner in the global pharmaceutical landscape, enabling access to life-enhancing medications for patients worldwide.
Company Details
Key Leadership
Latest News
SYSCHEM Share Price: Frequently Asked Questions
What is the current share price of Syschem India Ltd (SYSCHEM)?
As of 30 Mar 2026, 11:00 am IST, Syschem India Ltd share price is ₹43.06. The SYSCHEM stock has a market capitalisation of ₹237.63 (Cr) on NSE/BSE.
Is SYSCHEM share price Overvalued or Undervalued?
SYSCHEM share price is currently trading at a P/E ratio of 52.46x, compared to the industry average of 31.77x. Based on this relative valuation, the Syschem India Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of SYSCHEM share price?
The 52-week high of SYSCHEM share price is ₹62.00 and the 52-week low is ₹35.33. These values are updated daily from NSE/BSE price data.
What factors affect the Syschem India Ltd share price?
Key factors influencing SYSCHEM share price include quarterly earnings growth (Sales Growth: 118.01%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Syschem India Ltd a good stock for long-term investment?
Syschem India Ltd shows a 5-year Profit Growth of 17.64% and an ROE of 0.62%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing in SYSCHEM shares.
How does Syschem India Ltd compare with its industry peers?
Syschem India Ltd competes with major peers in the Pharmaceuticals. Investors should compare SYSCHEM share price P/E of 52.46x and ROE of 0.62% against the industry averages to determine competitive standing.
What is the P/E ratio of SYSCHEM and what does it mean?
SYSCHEM share price has a P/E ratio of 52.46x compared to the industry average of 31.77x. Investors pay ₹52 for every ₹1 of annual earnings.
How is SYSCHEM performing according to Bull Run's analysis?
SYSCHEM has a Bull Run fundamental score of 58.4/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does SYSCHEM belong to?
SYSCHEM operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Syschem India Ltd share price.
What is Return on Equity (ROE) and why is it important for SYSCHEM?
SYSCHEM has an ROE of 0.62%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Syschem India Ltd generates profits from shareholders capital.
How is SYSCHEM debt-to-equity ratio and what does it indicate?
SYSCHEM has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk.
What is SYSCHEM dividend yield and is it a good dividend stock?
SYSCHEM offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Syschem India Ltd shares.
How has SYSCHEM share price grown over the past 5 years?
SYSCHEM has achieved 5-year growth rates of: Sales Growth 33.94%, Profit Growth 17.64%, and EPS Growth 16.40%.
What is the promoter holding in SYSCHEM and why does it matter?
Promoters hold 56.71% of SYSCHEM shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Syschem India Ltd.
What is SYSCHEM market capitalisation category?
SYSCHEM has a market capitalisation of ₹238 crores, placing it in the Small-cap category.
How volatile is SYSCHEM stock?
SYSCHEM has a beta of N/A. A beta > 1 suggests the Syschem India Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is SYSCHEM operating profit margin trend?
SYSCHEM has a 5-year average Operating Profit Margin (OPM) of 1.98%, indicating the company's operational efficiency.
How is SYSCHEM quarterly performance?
Recent quarterly performance shows Syschem India Ltd YoY Sales Growth of 118.01% and YoY Profit Growth of 396.88%.
What is the institutional holding pattern in SYSCHEM?
SYSCHEM has FII holding of 0.00% and DII holding of 0.18%. Significant institutional holding often suggests professional confidence in the Syschem India Ltd stock.